These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15865605)

  • 1. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
    Mylona E; Kapranou A; Mavrommatis J; Markaki S; Keramopoulos A; Nakopoulou L
    APMIS; 2005 Apr; 113(4):246-55. PubMed ID: 15865605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
    Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
    Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
    Mylona EE; Alexandrou PT; Giannopoulou IA; Rafailidis PI; Markaki S; Keramopoulos A; Nakopoulou LL
    Cancer Detect Prev; 2006; 30(2):111-7. PubMed ID: 16632244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer.
    Nakopoulou L; Katsarou S; Giannopoulou I; Alexandrou P; Tsirmpa I; Panayotopoulou E; Mavrommatis J; Keramopoulos A
    Mod Pathol; 2002 Jan; 15(1):26-34. PubMed ID: 11796838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
    Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
    Chung GG; Zerkowski MP; Ocal IT; Dolled-Filhart M; Kang JY; Psyrri A; Camp RL; Rimm DL
    Cancer; 2004 May; 100(10):2084-92. PubMed ID: 15139049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.
    Park DW; Ryu HS; Choi DS; Park YH; Chang KH; Min CK
    Gynecol Oncol; 2001 Sep; 82(3):442-9. PubMed ID: 11520138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR; Di Silverio F; Gentile V
    Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
    Aihara R; Mochiki E; Nakabayashi T; Akazawa K; Asao T; Kuwano H
    Br J Surg; 2005 Apr; 92(4):454-62. PubMed ID: 15609380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
    Nakopoulou L; Panayotopoulou EG; Giannopoulou I; Alexandrou P; Katsarou S; Athanassiadou P; Keramopoulos A
    Mod Pathol; 2002 Nov; 15(11):1154-61. PubMed ID: 12429794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
    Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P
    Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
    Mylona E; Nomikos A; Magkou C; Kamberou M; Papassideri I; Keramopoulos A; Nakopoulou L
    Histopathology; 2007 Feb; 50(3):338-47. PubMed ID: 17257129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Ropponen K; Kosma VM
    Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival.
    Nakopoulou L; Tsirmpa I; Alexandrou P; Louvrou A; Ampela C; Markaki S; Davaris PS
    Breast Cancer Res Treat; 2003 Jan; 77(2):145-55. PubMed ID: 12602913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.